Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial
Launched by WUERZBURG UNIVERSITY HOSPITAL · Oct 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to program deep brain stimulation (DBS) for people with dystonia, a condition that causes involuntary muscle contractions. The study aims to see if using a computer model to guide the programming of DBS can lead to better outcomes compared to the traditional methods used by doctors. This is important because while DBS can help many patients, some do not respond well to the treatment, and it can take time to see any improvements after changes are made.
To participate in this trial, you should be between the ages of 65 and 74 and have been receiving DBS for dystonia for over a year, with your treatment stable for the last three months. You’ll need to understand the study and provide your consent. If you join, you will be randomly assigned to receive either the new computer-guided programming or the standard programming, and your dystonia severity will be assessed to see which method works better. This trial is currently recruiting participants and aims to improve treatment options for individuals with this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic deep brain stimulation (\> 1 year) in the internal globus pallidus in patients with isolated dystonia.
- • Deep brain stimulation settings and dystonia medication stable for \> 3 months.
- • Understanding about and consent to the study and signed informed consent form.
- Exclusion Criteria:
- • Relevant comorbidities that might interfere with study endpoints (esp. palliative disease and severe neurologic or psychiatric comorbidities).
About Wuerzburg University Hospital
Würzburg University Hospital, a leading academic medical center in Germany, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution within the University of Würzburg, it combines cutting-edge scientific inquiry with comprehensive patient care. The hospital is committed to improving medical outcomes by fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities. With a focus on translating research findings into practical applications, Würzburg University Hospital plays a pivotal role in driving medical advancements and enhancing patient quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Würzburg, Bavaria, Germany
Patients applied
Trial Officials
Martin Reich
Principal Investigator
Department of Neurology - University Hosiptal Würzburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials